Medicus Pharma MDCX

Medicus Pharma announces share consolidation

Securities offering

Form
424B3
Filed
Importance
Routine
  1. 50-to-1 share consolidation effective October 12, 2026
  2. Common shares to trade under same ticker MDCX
  3. Intended to increase bid price and regain Nasdaq compliance

Written from the 424B3 on EDGAR. Check the filing before you rely on it.

Get an email when Medicus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.